{"data":{"id":"us-tx/tex.-health-and-safety-code-489.001","jurisdiction":"us-tx","citation":"Tex. Health and Safety Code § 489.001","heading":"DEFINITIONS.","body":"In this chapter:\n(1) \"Investigational drug, biological product, or device\" means a drug, biological product, or device that has successfully completed phase one of a clinical trial but has not yet been approved for general use by the United States Food and Drug Administration and remains under investigation in the clinical trial.\n(2) \"Terminal illness\" means an advanced stage of a disease with an unfavorable prognosis that, without life-sustaining procedures, will soon result in death or a state of permanent unconsciousness from which recovery is unlikely.\nAdded by Acts 2015, 84th Leg., R.S., Ch. 502 (H.B. 21), Sec. 2, eff. June 16, 2015.","path":["HEALTH AND SAFETY CODE","TITLE 6. FOOD, DRUGS, ALCOHOL, AND HAZARDOUS SUBSTANCES","SUBTITLE C. SUBSTANCE ABUSE REGULATION AND CRIMES","CHAPTER 489. ACCESS TO INVESTIGATIONAL TREATMENTS FOR PATIENTS WITH TERMINAL ILLNESSES","SUBCHAPTER A. GENERAL PROVISIONS"],"source_url":"https://statutes.capitol.texas.gov/Docs/HS/htm/HS.489.htm#489.001","current_through":"89th 2nd Called Legislative Session, 2025","vintage":"","retrieved_at":"2026-08-27T01:47:17Z","sha256":"268d918df87ba3a06def0106c18e31393718f750a3422156550d8ae6bca7c6df","source_id":"us-tx","stale":false,"prev":"us-tx/tex.-health-and-safety-code-488.005","next":"us-tx/tex.-health-and-safety-code-489.051"},"notice":"GroundRules: Original legal text. Not legal advice."}